Učitavanje...
Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure
The cardiovascular (CV) benefit and safety of treating low testosterone conditions is a matter of debate. Although testosterone deficiency has been linked to a rise in major adverse CV events, most of the studies on testosterone replacement therapy were not designed to assess CV risk and thus exclud...
Spremljeno u:
| Izdano u: | Rev Endocr Metab Disord |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer US
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8087565/ https://ncbi.nlm.nih.gov/pubmed/33616800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11154-021-09628-2 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|